Drug class in one race
P2Y12 platelet receptor drugs for Atherosclerotic Cardiovascular Disease
2 tracked P2Y12 platelet receptor drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the P2Y12 platelet receptor page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
1 Phase 31 Phase 1
Head-to-head evidence: CG-0255 vs Vicagrel